Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 216 entries
Sorted by: Best Match Show Resources per page
Uniportal Endoscopic Lumbar Interbody Fusion.

Neurospine

Wagner R, Haefner M.
PMID: 32746525
Neurospine. 2020 Jul;17:S120-S128. doi: 10.14245/ns.2040130.065. Epub 2020 Jul 31.

The cause of radiculopathy is the compression of the nerve root which can be secondary to sliding of the vertebra and reduced disc height. In some patients, decompression alone does not resolve this problem. We describe the uniportal endoscopic...

Cite
Wagner R, Haefner M. Uniportal Endoscopic Lumbar Interbody Fusion. Neurospine. 2020;17:S120-S128doi: 10.14245/ns.2040130.065.
Wagner, R., & Haefner, M. (2020). Uniportal Endoscopic Lumbar Interbody Fusion. Neurospine, 17S120-S128. https://doi.org/10.14245/ns.2040130.065
Wagner, Ralf, and Haefner, Monika. "Uniportal Endoscopic Lumbar Interbody Fusion." Neurospine vol. 17 (2020): S120-S128. doi: https://doi.org/10.14245/ns.2040130.065
Wagner R, Haefner M. Uniportal Endoscopic Lumbar Interbody Fusion. Neurospine. 2020 Jul;17:S120-S128. doi: 10.14245/ns.2040130.065. Epub 2020 Jul 31. PMID: 32746525; PMCID: PMC7410390.
Copy Download .nbib Format: NLM
Efficacy and safety of a new low-volume PEG with citrate and simethicone bowel preparation for colonoscopy (Clensia): a multicenter randomized observer-blind clinical trial vs. a low-volume PEG with ascorbic acid (PEG-ASC).

Endoscopy international open

Kump P, Hassan C, Spada C, Brownstone E, Datz C, Haefner M, Renner F, Schoefl R, Schreiber F.
PMID: 30083580
Endosc Int Open. 2018 Aug;6(8):E907-E913. doi: 10.1055/a-0624-2266. Epub 2018 Aug 01.

BACKGROUND AND STUDY AIMS : Quality of inspection during colonoscopy is strictly related to the level of cleansing. High-volume (PEG-based) solutions are highly effective and safe, but their high volume affects tolerability and compliance. The aim of this study...

Cite
Kump P, Hassan C, Spada C, et al. Efficacy and safety of a new low-volume PEG with citrate and simethicone bowel preparation for colonoscopy (Clensia): a multicenter randomized observer-blind clinical trial vs. a low-volume PEG with ascorbic acid (PEG-ASC). Endosc Int Open. 2018;6(8):E907-E913doi: 10.1055/a-0624-2266.
Kump, P., Hassan, C., Spada, C., Brownstone, E., Datz, C., Haefner, M., Renner, F., Schoefl, R., & Schreiber, F. (2018). Efficacy and safety of a new low-volume PEG with citrate and simethicone bowel preparation for colonoscopy (Clensia): a multicenter randomized observer-blind clinical trial vs. a low-volume PEG with ascorbic acid (PEG-ASC). Endoscopy international open, 6(8), E907-E913. https://doi.org/10.1055/a-0624-2266
Kump, Patrizia, et al. "Efficacy and safety of a new low-volume PEG with citrate and simethicone bowel preparation for colonoscopy (Clensia): a multicenter randomized observer-blind clinical trial vs. a low-volume PEG with ascorbic acid (PEG-ASC)." Endoscopy international open vol. 6,8 (2018): E907-E913. doi: https://doi.org/10.1055/a-0624-2266
Kump P, Hassan C, Spada C, Brownstone E, Datz C, Haefner M, Renner F, Schoefl R, Schreiber F. Efficacy and safety of a new low-volume PEG with citrate and simethicone bowel preparation for colonoscopy (Clensia): a multicenter randomized observer-blind clinical trial vs. a low-volume PEG with ascorbic acid (PEG-ASC). Endosc Int Open. 2018 Aug;6(8):E907-E913. doi: 10.1055/a-0624-2266. Epub 2018 Aug 01. PMID: 30083580; PMCID: PMC6070370.
Copy Download .nbib Format: NLM
Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases.

Molecular oncology

Severson TM, Zhu Y, De Marzo AM, Jones T, Simons JW, Nelson WG, Yegnasubramanian S, Freedman ML, Wessels L, Bergman AM, Haffner MC, Zwart W.
PMID: 33576154
Mol Oncol. 2021 Jul;15(7):1942-1955. doi: 10.1002/1878-0261.12923. Epub 2021 Mar 11.

The epigenomic regulation of transcriptional programs in metastatic prostate cancer is poorly understood. We studied the epigenomic landscape of prostate cancer drivers using transcriptional profiling and ChIP-seq in four clonal metastatic tumors derived from a single prostate cancer patient....

Cite
Severson TM, Zhu Y, De Marzo AM, et al. Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases. Mol Oncol. 2021;15(7):1942-1955doi: 10.1002/1878-0261.12923.
Severson, T. M., Zhu, Y., De Marzo, A. M., Jones, T., Simons, J. W., Nelson, W. G., Yegnasubramanian, S., Freedman, M. L., Wessels, L., Bergman, A. M., Haffner, M. C., & Zwart, W. (2021). Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases. Molecular oncology, 15(7), 1942-1955. https://doi.org/10.1002/1878-0261.12923
Severson, Tesa M, et al. "Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases." Molecular oncology vol. 15,7 (2021): 1942-1955. doi: https://doi.org/10.1002/1878-0261.12923
Severson TM, Zhu Y, De Marzo AM, Jones T, Simons JW, Nelson WG, Yegnasubramanian S, Freedman ML, Wessels L, Bergman AM, Haffner MC, Zwart W. Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases. Mol Oncol. 2021 Jul;15(7):1942-1955. doi: 10.1002/1878-0261.12923. Epub 2021 Mar 11. PMID: 33576154; PMCID: PMC8253095.
Copy Download .nbib Format: NLM
Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130.

Oncogene

Kwon OJ, Zhang B, Jia D, Zhang L, Wei X, Zhou Z, Liu D, Huynh KT, Zhang K, Zhang Y, Labhart P, Sboner A, Barbieri C, Haffner MC, Creighton CJ, Xin L.
PMID: 34999736
Oncogene. 2022 Jan 08; doi: 10.1038/s41388-021-02169-7. Epub 2022 Jan 08.

Macrophages are increased in human benign prostatic hyperplasia and prostate cancer. We generate a Pb-Csf1 mouse model with prostate-specific overexpression of macrophage colony-stimulating factor (M-Csf/Csf1). Csf1 overexpression promotes immune cell infiltration into the prostate, modulates the macrophage polarity in...

Cite
Kwon OJ, Zhang B, Jia D, et al. Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130. Oncogene. 2022;doi: 10.1038/s41388-021-02169-7.
Kwon, O. J., Zhang, B., Jia, D., Zhang, L., Wei, X., Zhou, Z., Liu, D., Huynh, K. T., Zhang, K., Zhang, Y., Labhart, P., Sboner, A., Barbieri, C., Haffner, M. C., Creighton, C. J., & Xin, L. (2022). Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130. Oncogene, . https://doi.org/10.1038/s41388-021-02169-7
Kwon, Oh-Joon, et al. "Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130." Oncogene vol. (2022). doi: https://doi.org/10.1038/s41388-021-02169-7
Kwon OJ, Zhang B, Jia D, Zhang L, Wei X, Zhou Z, Liu D, Huynh KT, Zhang K, Zhang Y, Labhart P, Sboner A, Barbieri C, Haffner MC, Creighton CJ, Xin L. Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130. Oncogene. 2022 Jan 08; doi: 10.1038/s41388-021-02169-7. Epub 2022 Jan 08. PMID: 34999736.
Copy Download .nbib Format: NLM
Noninvasive Detection of Intracranial Hypertension by Novel Ultrasound Time-Harmonic Elastography.

Investigative radiology

Kreft B, Tzschätzsch H, Shahryari M, Haffner P, Braun J, Sack I, Streitberger KJ.
PMID: 34380993
Invest Radiol. 2022 Feb 01;57(2):77-84. doi: 10.1097/RLI.0000000000000817.

OBJECTIVE: A method for measuring intracranial pressure (ICP) noninvasively has long been sought after in neurology and neurosurgery. Treatment failure in individuals presenting with unspecific symptoms such as headache, gait disturbance, or visual impairment occurring in response to increased...

Cite
Kreft B, Tzschätzsch H, Shahryari M, et al. Noninvasive Detection of Intracranial Hypertension by Novel Ultrasound Time-Harmonic Elastography. Invest Radiol. 2022;57(2):77-84doi: 10.1097/RLI.0000000000000817.
Kreft, B., Tzschätzsch, H., Shahryari, M., Haffner, P., Braun, J., Sack, I., & Streitberger, K. J. (2022). Noninvasive Detection of Intracranial Hypertension by Novel Ultrasound Time-Harmonic Elastography. Investigative radiology, 57(2), 77-84. https://doi.org/10.1097/RLI.0000000000000817
Kreft, Bernhard, et al. "Noninvasive Detection of Intracranial Hypertension by Novel Ultrasound Time-Harmonic Elastography." Investigative radiology vol. 57,2 (2022): 77-84. doi: https://doi.org/10.1097/RLI.0000000000000817
Kreft B, Tzschätzsch H, Shahryari M, Haffner P, Braun J, Sack I, Streitberger KJ. Noninvasive Detection of Intracranial Hypertension by Novel Ultrasound Time-Harmonic Elastography. Invest Radiol. 2022 Feb 01;57(2):77-84. doi: 10.1097/RLI.0000000000000817. PMID: 34380993.
Copy Download .nbib Format: NLM
Presenting features and long-term effects of growth hormone treatment of children with optic nerve hypoplasia/septo-optic dysplasia.

International journal of pediatric endocrinology

Vedin AM, Karlsson H, Fink C, Borchert M, Geffner ME.
PMID: 22085631
Int J Pediatr Endocrinol. 2011 Nov 15;2011(1):17. doi: 10.1186/1687-9856-2011-17.

BACKGROUND: Optic nerve hypoplasia (ONH) with/or without septo-optic dysplasia (SOD) is a known concomitant of congenital growth hormone deficiency (CGHD).METHODS: Demographic and longitudinal data from KIGS, the Pfizer International Growth Database, were compared between 395 subjects with ONH/SOD and...

Cite
Vedin AM, Karlsson H, Fink C, et al. Presenting features and long-term effects of growth hormone treatment of children with optic nerve hypoplasia/septo-optic dysplasia. Int J Pediatr Endocrinol. 2011;2011(1):17doi: 10.1186/1687-9856-2011-17.
Vedin, A. M., Karlsson, H., Fink, C., Borchert, M., & Geffner, M. E. (2011). Presenting features and long-term effects of growth hormone treatment of children with optic nerve hypoplasia/septo-optic dysplasia. International journal of pediatric endocrinology, 2011(1), 17. https://doi.org/10.1186/1687-9856-2011-17
Vedin, Amy M, et al. "Presenting features and long-term effects of growth hormone treatment of children with optic nerve hypoplasia/septo-optic dysplasia." International journal of pediatric endocrinology vol. 2011,1 (2011): 17. doi: https://doi.org/10.1186/1687-9856-2011-17
Vedin AM, Karlsson H, Fink C, Borchert M, Geffner ME. Presenting features and long-term effects of growth hormone treatment of children with optic nerve hypoplasia/septo-optic dysplasia. Int J Pediatr Endocrinol. 2011 Nov 15;2011(1):17. doi: 10.1186/1687-9856-2011-17. PMID: 22085631; PMCID: PMC3256097.
Copy Download .nbib Format: NLM
Laser direct writing of rotationally symmetric high-resolution structures.

Applied optics

Haefner M, Pruss C, Osten W.
PMID: 22086024
Appl Opt. 2011 Nov 01;50(31):5983-9. doi: 10.1364/AO.50.005983.

We present a laser direct writing system for the efficient fabrication of high-resolution axicon structures. The setup makes use of scanning beam interference lithography incorporated with a fringe locking scheme for tight fringe phase control and allows us to...

Cite
Haefner M, Pruss C, Osten W. Laser direct writing of rotationally symmetric high-resolution structures. Appl Opt. 2011;50(31):5983-9doi: 10.1364/AO.50.005983.
Haefner, M., Pruss, C., & Osten, W. (2011). Laser direct writing of rotationally symmetric high-resolution structures. Applied optics, 50(31), 5983-9. https://doi.org/10.1364/AO.50.005983
Haefner, Matthias, et al. "Laser direct writing of rotationally symmetric high-resolution structures." Applied optics vol. 50,31 (2011): 5983-9. doi: https://doi.org/10.1364/AO.50.005983
Haefner M, Pruss C, Osten W. Laser direct writing of rotationally symmetric high-resolution structures. Appl Opt. 2011 Nov 01;50(31):5983-9. doi: 10.1364/AO.50.005983. PMID: 22086024.
Copy Download .nbib Format: NLM
Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer.

JCI insight

De Sarkar N, Dasgupta S, Chatterjee P, Coleman I, Ha G, Ang LS, Kohlbrenner EA, Frank SB, Nunez TA, Salipante SJ, Corey E, Morrissey C, Van Allen E, Schweizer MT, Haffner MC, Patel R, Hanratty B, Lucas JM, Dumpit RF, Pritchard CC, Montgomery RB, Nelson PS.
PMID: 34877933
JCI Insight. 2021 Dec 08;6(23). doi: 10.1172/jci.insight.152789.

Cancers with homology-directed DNA repair (HRR) deficiency exhibit high response rates to poly(ADP-ribose) polymerase inhibitors (PARPi) and platinum chemotherapy. Though mutations disrupting BRCA1 and BRCA2 associate with HRR deficiency (HRRd), patterns of genomic aberrations and mutation signatures may be...

Cite
De Sarkar N, Dasgupta S, Chatterjee P, et al. Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer. JCI Insight. 2021;6(23)doi: 10.1172/jci.insight.152789.
De Sarkar, N., Dasgupta, S., Chatterjee, P., Coleman, I., Ha, G., Ang, L. S., Kohlbrenner, E. A., Frank, S. B., Nunez, T. A., Salipante, S. J., Corey, E., Morrissey, C., Van Allen, E., Schweizer, M. T., Haffner, M. C., Patel, R., Hanratty, B., Lucas, J. M., Dumpit, R. F., Pritchard, C. C., Montgomery, R. B., & Nelson, P. S. (2021). Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer. JCI insight, 6(23), . https://doi.org/10.1172/jci.insight.152789
De Sarkar, Navonil, et al. "Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer." JCI insight vol. 6,23 (2021). doi: https://doi.org/10.1172/jci.insight.152789
De Sarkar N, Dasgupta S, Chatterjee P, Coleman I, Ha G, Ang LS, Kohlbrenner EA, Frank SB, Nunez TA, Salipante SJ, Corey E, Morrissey C, Van Allen E, Schweizer MT, Haffner MC, Patel R, Hanratty B, Lucas JM, Dumpit RF, Pritchard CC, Montgomery RB, Nelson PS. Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer. JCI Insight. 2021 Dec 08;6(23). doi: 10.1172/jci.insight.152789. PMID: 34877933.
Copy Download .nbib Format: NLM
[Options and limits of arthroscopic treatment of joint empyema].

Der Unfallchirurg

Osti M, Simkovic M, Haffner N.
PMID: 34874471
Unfallchirurg. 2021 Dec 07; doi: 10.1007/s00113-021-01111-6. Epub 2021 Dec 07.

Due to its low invasive nature, arthroscopy nowadays represents the gold standard in the treatment of native joint empyema. This article gives a summary of the literature with expert recommendations, reviews and case reports on arthroscopic treatment of native...

Cite
Osti M, Simkovic M, Haffner N. Optionen und Grenzen der arthroskopischen Behandlung von Gelenkempyemen. [Options and limits of arthroscopic treatment of joint empyema]. Unfallchirurg. 2021;doi: 10.1007/s00113-021-01111-6.
Osti, M., Simkovic, M., & Haffner, N. (2021). Optionen und Grenzen der arthroskopischen Behandlung von Gelenkempyemen. [Options and limits of arthroscopic treatment of joint empyema]. Der Unfallchirurg, . https://doi.org/10.1007/s00113-021-01111-6
Osti, Michael, et al. "Optionen und Grenzen der arthroskopischen Behandlung von Gelenkempyemen." [Options and limits of arthroscopic treatment of joint empyema]. Der Unfallchirurg vol. (2021). doi: https://doi.org/10.1007/s00113-021-01111-6
Osti M, Simkovic M, Haffner N. Optionen und Grenzen der arthroskopischen Behandlung von Gelenkempyemen. [Options and limits of arthroscopic treatment of joint empyema]. Unfallchirurg. 2021 Dec 07; doi: 10.1007/s00113-021-01111-6. Epub 2021 Dec 07. German. PMID: 34874471.
Copy Download .nbib Format: NLM
Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer.

JCI insight

Brennen WN, Zhu Y, Coleman IM, Dalrymple SL, Antony L, Patel RA, Hanratty B, Chikarmane R, Meeker AK, Zheng SL, Hooper JE, Luo J, De Marzo AM, Corey E, Xu J, Yegnasubramanian S, Haffner MC, Nelson PS, Nelson WG, Isaacs WB, Isaacs JT.
PMID: 33724955
JCI Insight. 2021 Apr 22;6(8). doi: 10.1172/jci.insight.146827.

Resistance to AR signaling inhibitors (ARSis) in a subset of metastatic castration-resistant prostate cancers (mCRPCs) occurs with the emergence of AR- neuroendocrine prostate cancer (NEPC) coupled with mutations/deletions in PTEN, TP53, and RB1 and the overexpression of DNMTs, EZH2,...

Cite
Brennen WN, Zhu Y, Coleman IM, et al. Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer. JCI Insight. 2021;6(8)doi: 10.1172/jci.insight.146827.
Brennen, W. N., Zhu, Y., Coleman, I. M., Dalrymple, S. L., Antony, L., Patel, R. A., Hanratty, B., Chikarmane, R., Meeker, A. K., Zheng, S. L., Hooper, J. E., Luo, J., De Marzo, A. M., Corey, E., Xu, J., Yegnasubramanian, S., Haffner, M. C., Nelson, P. S., Nelson, W. G., Isaacs, W. B., & Isaacs, J. T. (2021). Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer. JCI insight, 6(8), . https://doi.org/10.1172/jci.insight.146827
Brennen, W Nathaniel, et al. "Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer." JCI insight vol. 6,8 (2021). doi: https://doi.org/10.1172/jci.insight.146827
Brennen WN, Zhu Y, Coleman IM, Dalrymple SL, Antony L, Patel RA, Hanratty B, Chikarmane R, Meeker AK, Zheng SL, Hooper JE, Luo J, De Marzo AM, Corey E, Xu J, Yegnasubramanian S, Haffner MC, Nelson PS, Nelson WG, Isaacs WB, Isaacs JT. Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer. JCI Insight. 2021 Apr 22;6(8). doi: 10.1172/jci.insight.146827. PMID: 33724955; PMCID: PMC8119192.
Copy Download .nbib Format: NLM
Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy.

HIV medicine

Mmasa KN, Powis K, Sun S, Makhema J, Mmalane M, Kgole S, Masasa G, Moyo S, Gerschenson M, Mohammed T, Legbedze J, Abrams EJ, Kurland IJ, Geffner ME, Jao J.
PMID: 34003565
HIV Med. 2021 Sep;22(8):715-722. doi: 10.1111/hiv.13120. Epub 2021 May 18.

BACKGROUND: There are few data on the prevalence of gestational diabetes (GDM) in pregnant women living with HIV (WLHIV) in sub-Saharan Africa, particularly those using integrase strand transfer inhibitors such as dolutegravir (DTG).METHODS: We prospectively enrolled pregnant WLHIV and...

Cite
Mmasa KN, Powis K, Sun S, et al. Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy. HIV Med. 2021;22(8):715-722doi: 10.1111/hiv.13120.
Mmasa, K. N., Powis, K., Sun, S., Makhema, J., Mmalane, M., Kgole, S., Masasa, G., Moyo, S., Gerschenson, M., Mohammed, T., Legbedze, J., Abrams, E. J., Kurland, I. J., Geffner, M. E., & Jao, J. (2021). Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy. HIV medicine, 22(8), 715-722. https://doi.org/10.1111/hiv.13120
Mmasa, K N, et al. "Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy." HIV medicine vol. 22,8 (2021): 715-722. doi: https://doi.org/10.1111/hiv.13120
Mmasa KN, Powis K, Sun S, Makhema J, Mmalane M, Kgole S, Masasa G, Moyo S, Gerschenson M, Mohammed T, Legbedze J, Abrams EJ, Kurland IJ, Geffner ME, Jao J. Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy. HIV Med. 2021 Sep;22(8):715-722. doi: 10.1111/hiv.13120. Epub 2021 May 18. PMID: 34003565; PMCID: PMC8373729.
Copy Download .nbib Format: NLM
CT scans better assess lateral wall morphology of "stable appearing" intertrochanteric (IT) femur fractures and predict early failure of sliding hip screw (SHS) fixation.

OTA international : the open access journal of orthopaedic trauma

Hecht G, Saiz AM, Shelton TJ, Haffner MR, Delman C, Shieh A, Hallare J, Bhatti S, Wolinsky P.
PMID: 34746672
OTA Int. 2021 Aug 09;4(3):e140. doi: 10.1097/OI9.0000000000000140. eCollection 2021 Sep.

To compare the efficacy of plain x-ray images and computed tomography (CT) to assess the morphology of the lateral wall (LW) component of intertrochanteric (IT) femur fractures and determine predictors of early fixation failure.DESIGN: Retrospective cohort study.SETTING: Level-one trauma...

Cite
Hecht G, Saiz AM, Shelton TJ, et al. CT scans better assess lateral wall morphology of "stable appearing" intertrochanteric (IT) femur fractures and predict early failure of sliding hip screw (SHS) fixation. OTA Int. 2021;4(3):e140doi: 10.1097/OI9.0000000000000140.
Hecht, G., Saiz, A. M., Shelton, T. J., Haffner, M. R., Delman, C., Shieh, A., Hallare, J., Bhatti, S., & Wolinsky, P. (2021). CT scans better assess lateral wall morphology of "stable appearing" intertrochanteric (IT) femur fractures and predict early failure of sliding hip screw (SHS) fixation. OTA international : the open access journal of orthopaedic trauma, 4(3), e140. https://doi.org/10.1097/OI9.0000000000000140
Hecht, Garin, et al. "CT scans better assess lateral wall morphology of "stable appearing" intertrochanteric (IT) femur fractures and predict early failure of sliding hip screw (SHS) fixation." OTA international : the open access journal of orthopaedic trauma vol. 4,3 (2021): e140. doi: https://doi.org/10.1097/OI9.0000000000000140
Hecht G, Saiz AM, Shelton TJ, Haffner MR, Delman C, Shieh A, Hallare J, Bhatti S, Wolinsky P. CT scans better assess lateral wall morphology of "stable appearing" intertrochanteric (IT) femur fractures and predict early failure of sliding hip screw (SHS) fixation. OTA Int. 2021 Aug 09;4(3):e140. doi: 10.1097/OI9.0000000000000140. eCollection 2021 Sep. PMID: 34746672; PMCID: PMC8568429.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 216 entries